中国医科大学学报

中国医科大学学报
  • 中文核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
  • BA、CA收录

中国医科大学学报 ›› 2018, Vol. 47 ›› Issue (2): 137-140.doi: 10.12007/j.issn.0258-4646.2018.02.010

• 论著 • 上一篇    下一篇

经皮穿刺治疗经内镜引流失败的恶性梗阻性黄疸

谢锋1, 朱芳2, 刘峥嵘3, 王红岩3, 赵晓丹3, 樊小刚4   

  1. 1. 中国医科大学人民医院核医学科, 沈阳 110016;
    2. 中国医科大学人民医院心功能科, 沈阳 110016;
    3. 中国医科大学人民医院普外科, 沈阳 110016;
    4. 沈阳出入境检验检疫局国际旅行卫生保健中心, 沈阳 110016
  • 收稿日期:2017-10-23 出版日期:2018-02-28 发布日期:2018-01-11
  • 通讯作者: 朱芳 E-mail:zfmoon@126.com
  • 作者简介:谢锋(1977-),男,副主任医师,博士.
  • 基金资助:
    辽宁省社会发展公关计划(2013225021)

Percutaneous Puncture to Treat Malignant Obstructive Jaundice in Patients Who Fail Endoscopic Drainage

Xie Feng1, Zhu Fang2, Liu Zhengrong3, Wang Hongyan3, Zhao Xiaodan3, Fan Xiaogang4   

  1. 1. Department of Nuclear Medicine, The People's Hospital of China Medical University, Shenyang 110016, China;
    2. Department of Cardiac Function, The People's Hospital of China Medical University, Shenyang 110016, China;
    3. Department of General Surgery, The People's Hospital of China Medical University, Shenyang 110016, China;
    4. Shenyang Entry-exit Inspection and Quarantine Bureau International Travel Health Care Center, Shenyang 110016, China
  • Received:2017-10-23 Online:2018-02-28 Published:2018-01-11

摘要: 目的 探讨采用经皮经肝胆管穿刺引流术(PTCD)、经皮胆囊穿刺引流术、经皮经肝胆管内支架植入术治疗经内镜引流失败的恶性梗阻性黄疸的临床应用价值。方法 回顾性分析2015年8月至2017年7月行经内镜减黄失败后在我院行经皮穿刺减黄的梗阻性黄疸患者共17例。根据病变类型及术中情况选择不同的减黄方法,其中9例行经皮经肝胆管内支架植入术(53%)、5例行PTCD (29%)、3例行经皮胆囊穿刺引流术(18%)。采集术前1 d及术后1周患者的总胆红素和谷丙转氨酶,以二者手术前后的下降程度来评价经皮穿刺减黄治疗的效果;再以是否放置支架为条件,将患者分为支架组和置管组,以总胆红素、谷丙转氨酶的下降程度及患者生存期来评价2组的疗效差异。结果 总体患者手术前后总胆红素及谷丙转氨酶均有明显下降(P < 0.05)。支架组和置管组总胆红素、谷丙转氨酶的下降程度都没有明显差异(P > 0.05)。支架组患者的生存期长于置管组,2组比较有统计学差异(P < 0.05)。结论 经皮穿刺治疗经内镜引流失败的恶性梗阻性黄疸疗效确切。相对于留置引流管,放置支架可以更好的延长患者生存期。而对于总胆红素、谷丙转氨酶的下降方面,放置支架并不优于留置引流管。

关键词: 梗阻性黄疸, 经皮经肝胆管内支架植入术, 经皮经肝胆管引流术, 经皮胆囊穿刺引流术

Abstract: Objective To study the efficacy of percutaneous transhepatic cholangiodrainage (PTCD),percutaneous gallbladder drainage,and percutaneous transhepatic biliary stent implantation for the treatment of malignant obstructive jaundice in patients who are observed to fail endoscopic drainage.Methods We retrospectively analyzed 17 patients diagnosed with obstructive jaundice between August 2015 and July 2017 who were observed to have failed endoscopic drainage. Percutaneous puncture drainage had been performed in all patients-different methods were chosen based on the type of lesion and the patient's intraoperative condition. Among these patients,9 underwent percutaneous transhepatic biliary stent implantation (53%),5 underwent PTCD (29%),and 3 underwent percutaneous gallbladder drainage (18%). The serum levels of total bilirubin (TBIL) and alanine aminotransferase (ALT) were assessed a day preoperatively and a week postoperatively. The postoperative decrease (or drop) in the serum TBIL and ALT levels was used as a parameter to assess the efficacy of treatment. Patients were divided into a stent and a tube group. The therapeutic effects were compared between the groups in terms of the drop in the serum TBIL and ALT levels and the survival time of patients.Results The postoperative serum TBIL and ALT levels were significantly decreased in all patients (P < 0.05). No statistically significant difference was observed between the stent and the tube group in terms of the decrease in serum TBIL and ALT levels (P > 0.05). However,a statistically significant difference was observed between the stent and the tube group in terms of the survival time of patients (P < 0.05).Conclusion Percutaneous puncture is an effective treatment modality to manage malignant obstructive jaundice in patients who fail endoscopic drainage. Compared to tube drainage,stent placement can prolong patient survival time. Regarding the decrease in serum TBIL and ALT levels,we conclude that stent implantation is not significantly better than tube drainage.

Key words: obstructive jaundice, percutaneous transhepatic biliary stent implantation, percutaneous transhepatic cholangiodrainage, percutaneous gallbladder drainage

中图分类号: 

  • R45
[1] MATSUMOTO K,TAKEDA Y,ONOYAMA T,et al. Endoscopic treatment for distal malignant biliary obstruction[J]. Ann Transl Med,2017,5(8):190. DOI:10.21037/atm.2017.02.22.
[2] YARMOHAMMADI H,COVEY AM. Percutaneous biliary interventions and complications in malignant bile duct obstruction[J]. Chin Clin Oncol,2016,5(5):68. DOI:10.21037/cco.2016.10.07.
[3] DE SIMONE W,CRAFA F,NOVIELLO A,et al. Bilirubin removal with coupled plasma filtration and adsorption in patients affected by hilar cholangiocarcinoma[J]. G Ital Nefrol,2017,34(11/12):pii 2017-vol6.
[4] IMAMURA N,NANASHIMA A,TSUCHIMOCHI Y,et al. Intrahepatic portal vein thrombosis due to postoperative biliary obstruction successfully treated by a partial thrombectomy combined with thrombolytic drug therapy[J]. Int J Surg Case Rep,2017,42:20-23. DOI:10.1016/j.ijscr.2017.11.047.
[5] AHN S,LEE YS,LIM KS,et al. Malignant biliary obstructions can we predict immediate postprocedural cholangitis after percutaneous biliary drainage?[J].Support Care Cancer,2013,21(8):2321-2326. DOI:10.1007/s00520-013-1796-5.
[6] HATZIDAKIS AA,TSETIS D,CHRYSOU E,et al. Nitinol stents for palliative treatment of malignant obstructive jaundice:should we stent the sphincter of Oddi in every case?[J]. Cardiovasc Intervent Radiol,2001,24(4):245-248.
[7] SAHAI P,KUMAR S. External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma:available evidence[J]. Br J Radiol,2017,90(1076):20170061. DOI:10.1259/bjr.20170061.
[8] KONDO M,OKAMOTO E,TAKAGI K,et al. Insertion of percutaneous transhepatic biliary endoprosthesis for unresectable lower cholangiocellular carcinoma following cholangitis due to endoscopic biliary plastic stent obstruction[J]. Gan To Kagaku Ryoho,2013,40(12):1777-1779.
[9] LI X,YU J,LIANG P,et al. Ultrasound-guided percutaneous microwave ablation assisted by three-dimensional visualization operative treatment planning system and percutaneous transhepatic cholangial drainage with intraductal chilled saline perfusion for larger hepatic hilum hepatocellular (D ≥ 3 cm):preliminary results[J]. Oncotarget,2017,8(45):79742-79749. DOI:10.18632/oncotarget.19275.
[10] LANDI F,DE ANGELIS N,SEPULVEDA A,et al. Endoscopic treatment of anastomotic biliary stricture after adult deceased donor liver transplantation with multiple plastic stents versus self-expandable metal stents:a systematic review and meta-analysis[J]. Transpl Int,2017. DOI:10.1111/tri.13089.
[11] HUNG HH,CHEN TS,TSENG HS,et al. Percutaneous transhepatic cholangiography and drainage is an effective rescue therapy for biliary complications in liver transplant recipients who fail endoscopic retrograde cholangiopancreatography[J]. J Chin Med Assoc,2009,72(8):395-401. DOI:10.1016/S1726-4901(09) 70395-8.
[12] BEDREAG OH,ROGOBETE AF,SANDESC D,et al. Modulation of the redox expression and inflammation response in the Critically Ⅲpolytrauma patient with thoracic injury. Statistical correlations between antioxidant therapy[J]. Glin Lab,2016,62(9):1747-1759. DOI:10.7754/Clin.Lab.2016.160206.
[13] XU C,LV PH,HUANG XE,et al. Analysis of different ways of drainage for obstructive jaundice caused by hilar cholangiocarcinoma[J]. Asian Pac J Cancer Prev,2014,15(14):5617-5620.
[14] FRANCESCHET I,ZANETTO A,FERRARESE A,et al. Therapeutic approaches for portal biliopathy:a systematic review[J]. World J Gastroenterol,2016,22(45):9909-9920. DOI:10.3748/wjg.v22.i45.9909.
[15] WESTWOOD DA,FEMANDO C,CONNOR SJ. Internal-external percutaneous transhepatic biliary drainage for malignant biliary obstruction:a retrospective analysis[J]. J Med Imaging Radiat Oncol,2010,54(2):108-110. DOI:10.1111/j.1754-9485.2010.02147.x.
[1] 谢锋, 朱芳, 王红岩, 刘峥嵘, 赵晓丹, 樊小刚, 韩宏民. 经皮胆囊穿刺引流术辅助治疗重症急性胰腺炎的临床应用价值[J]. 中国医科大学学报, 2018, 47(3): 244-246.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!

中国医科大学学报版权所有©2018

未经允许,严禁擅自转载本站图文资料

地址:中国 沈阳市沈北新区蒲河路77号 110122

辽ICP备05014850

JOURNAL OF CHINA MEDICAL UNIVERSITY

ADDRESS: NO.77 PUHE ROAD

SHENYANG NORTH NEW AREA, SHENYANG

LIAONING PROVINCE, P.R. CHINA